These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 16331242
1. Ambien CR for insomnia. Med Lett Drugs Ther; ; 47(1223-1224):97-8. PubMed ID: 16331242 [No Abstract] [Full Text] [Related]
2. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms. Barkin RL. Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707 [Abstract] [Full Text] [Related]
3. Zolpidem for insomnia. Med Lett Drugs Ther; 1993 Apr 30; 35(895):35-6. PubMed ID: 8386301 [No Abstract] [Full Text] [Related]
4. Zolpidem--a hypnotic with a difference? Drug Ther Bull; 1995 May 30; 33(5):37-9. PubMed ID: 7587994 [No Abstract] [Full Text] [Related]
5. Zolpidem: a review of its use in the management of insomnia. Swainston Harrison T, Keating GM. CNS Drugs; 2005 May 30; 19(1):65-89. PubMed ID: 15651908 [Abstract] [Full Text] [Related]
6. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group. Sleep Med; 2006 Aug 30; 7(5):397-406. PubMed ID: 16815744 [Abstract] [Full Text] [Related]
7. [New non-benzodiazepine hypnotics. Progress in therapy of sleep disorders?]. Hajak G, Rüther E. Internist (Berl); 1995 Nov 30; 36(11):1085-90; discussion 1090-1. PubMed ID: 8543446 [No Abstract] [Full Text] [Related]
8. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Jhaveri M, Seal B, Pollack M, Wertz D. Curr Med Res Opin; 2007 Jun 30; 23(6):1431-43. PubMed ID: 17559740 [Abstract] [Full Text] [Related]
10. Zolpidem and driving impairment--identifying persons at risk. Farkas RH, Unger EF, Temple R. N Engl J Med; 2013 Aug 22; 369(8):689-91. PubMed ID: 23923991 [No Abstract] [Full Text] [Related]
11. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance. Bogan RK. Postgrad Med; 2008 Sep 22; 120(3):161-71. PubMed ID: 18824834 [Abstract] [Full Text] [Related]
12. NICE review: not nice for patients! Alford C, Verster J. J Psychopharmacol; 2005 Mar 22; 19(2):129-32. PubMed ID: 15728431 [No Abstract] [Full Text] [Related]
13. Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. Erman M, Guiraud A, Joish VN, Lerner D. Sleep; 2008 Oct 22; 31(10):1371-8. PubMed ID: 18853934 [Abstract] [Full Text] [Related]
14. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study. Voshaar RC, van Balkom AJ, Zitman FG. Eur Neuropsychopharmacol; 2004 Aug 22; 14(4):301-6. PubMed ID: 15163440 [Abstract] [Full Text] [Related]
15. Consequences of insomnia and its therapies. Benca RM. J Clin Psychiatry; 2001 Aug 22; 62 Suppl 10():33-8. PubMed ID: 11388589 [Abstract] [Full Text] [Related]
16. Extensive craving in high dose zolpidem dependency. Svitek J, Heberlein A, Bleich S, Wiltfang J, Kornhuber J, Hillemacher T. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):591-2. PubMed ID: 18068286 [No Abstract] [Full Text] [Related]
17. NICE: The National Institute of Clinical Excellence -- or Eccentricity? Reflections on the Z-drugs as hypnotics. Nutt DJ. J Psychopharmacol; 2005 Mar 15; 19(2):125-7. PubMed ID: 15728430 [No Abstract] [Full Text] [Related]
19. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia. Lankford A, Ancoli-Israel S. Int J Clin Pract; 2007 Jun 15; 61(6):1037-45. PubMed ID: 17386060 [Abstract] [Full Text] [Related]